1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71(3): 209-49.
2. Wo JY, Anker CJ, Ashman JB, Bhadkamkar NA, Bradfield L, Chang DT, et al. Radiation therapy for rectal cancer: executive summary of an ASTRO clinical practice guideline. Pract Radiat Oncol 2021; 11(1): 13-25.
3. Youssef FF, Parikh PJ, DeWees TA, Mutch MG, Tan Jr BR, Grigsby PW, et al. Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy. Adv Radiat Oncol 2016; 1(2): 94-100.
4. Yu M, Lee JH, Jang HS, Jeon DM, Cheon JS, Lee HC, et al. A comparison of dosimetric parameters between tomotherapy and three-dimensional conformal radiotherapy in rectal cancer. Radiat Oncol 2013; 8: 181.
5. Teoh S, Muirhead R. Rectal radiotherapy—Intensity-modulated radiotherapy delivery, delineation and doses. Clin Oncol (R Coll Radiol) 2016; 28(2): 93-102.
6. Sterzing F, Kalz J, Sroka-Perez G, Schubert K, Bischof M, Röder F, et al. Megavoltage CT in helical tomotherapy—clinical advantages and limitations of special physical characteristics. Technol Cancer Res Treat 2009; 8(5): 343-52.
7. Metcalfe P, Liney GP, Holloway L, Walker A, Barton M, Delaney GP, et al. The potential for an enhanced role for MRI in radiation-therapy treatment planning. Technol Cancer Res Treat 2013; 12(5): 429-46.
8. Balyasnikova S, Brown G. Optimal imaging strategies for rectal cancer staging and ongoing management. Curr Treat Options Oncol 2016; 17(6): 32.
9. Brunt JNH. Computed tomography–magnetic resonance image registration in radiotherapy treatment planning. Clin Oncol (R Coll Radiol) 2010; 22(8): 688-97.
10. Sarolkar A, Singh SN, Bagdare P, Bhandari V, Lodi AI, Moharir S. To evaluate volume changes on computerized tomography scan and magnetic resonance imaging-based delineation during radiotherapy treatment planning in prostate cancer. Journal of Cancer Research and Therapeutics 2021; 17(2): 379-82.
11. Tan J, Lim Joon D, Fitt G, Wada M, Lim Joon M, Mercuri A, Marr M, Chao M, Khoo V. The utility of multimodality imaging with CT and MRI in defining rectal tumour volumes for radiotherapy treatment planning: a pilot study. J Med Imaging Radiat Oncol 2010; 54(6): 562-8.
12. Gwynne S, Mukherjee S, Webster R, Spezi E, Staffurth J, Coles B, et al. Imaging for target volume delineation in rectal cancer radiotherapy—a systematic review. Clin Oncol (R Coll Radiol) 2012; 24(1): 52-63.
13. Kerkhof EM, Balter JM, Vineberg KA, Eisbruch A. Clinical application of a simple MR-to-CT registration method for improved target delineation in radiotherapy. Radiother Oncol 2010; 96(2): 165–9.
14. White I, Hunt A, Bird T, Settatree S, Soliman H, Mcquaid D, et al. Interobserver variability in target volume delineation for CT/MRI simulation and MRI-guided adaptive radiotherapy in rectal cancer. Br J Radiol. 2021; 94(1128): 20210350.
15. Rahmani D, Shahbazi-Gahrouei D, Roayaei M. Evaluating the Effect of Co-Registered Diagnostic MR Images Based CT Simulation on Target Volume Delineation and Dose Distribution for Tomotherapy of Rectal Cancer. J Biomed Phys Eng 2025; 15(239): 239-48.
16. Bird D, Nix MG, McCallum H, Teo M, Gilbert A, Casanova N, et al. The benefit of MR‐only radiotherapy treatment planning for anal and rectal cancers: A planning study. J Appl Clin Med Phys 2021; 22(11): 41-53.
17. Vojtíšek R, Mužík J, Šlampa P, Budíková M, Hejsek J, Smolák P, et al. The impact of PET/CT scanning on the size of target volumes, radiation exposure of organs at risk, TCP and NTCP, in the radiotherapy planning of non-small cell lung cancer. Rep Pract Oncol Radiother 2014; 19(3): 182-90.
18. Oh S, Kim S. Deformable image registration in radiation therapy. Radiat Oncol J 2017; 35(2): 101-11.
19. Myerson RJ, Garofalo MC, El Naqa I, Abrams RA, Apte A, Bosch WR, et al. Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys 2009; 74(3): 824-30.
20. Gay HA, Niemierko A. A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy. Phys Med 2007; 23(3-4): 115-25.
21. Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 1991; 21(1): 123-35.
22. O’Neill BDP, Salerno G, Thomas K, Tait DM, Brown G. MR vs CT imaging: low rectal cancer tumour delineation for three-dimensional conformal radiotherapy. Br J Radiol 2009; 82(978): 509-13.
23. Kulik C, Mazurier J, Lartigau E. Probabilities of controlling tumors and complications (TCP/NTCP) after radiotherapy: Methodologic, physical, and biological aspects. Cancer Radiother 2002; 6(Suppl 1): 155s-165s.
